Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

Fig. 1

a Blood glucose levels on the first day of LAN-ATG administration. b Mean blood glucose within 7 days before and 2 to 4 weeks after the first injection of LAN-ATG. During this phase there was an individual adjustment of therapy with discontinuation or reduction of glucagon and/or diazoxide and additional carbohydrate supply. Glucagon/diazoxide and additional carbohydrate treatment, shown as 100% column at LAN-ATG injection, with weekly mean after LAN-ATG (column 0–100%). The second LAN-ATG injection was done between 2 and 4 weeks, based on individual clinical decisions. * Significance determined by Student’s t-test. *p < 0.05. c Percentage of blood glucose < 3.3 mmol/l among all recorded blood glucose values within 7 days before and 7 days after the first injection of LAN-ATG

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172